Nateglinide
Specifications
105816-04-4CAS Number
642-283-9EC Number
(2R)-3-phenyl-2-[(4-propan-2-ylcyclohexanecarbonyl)amino]propanoic acidIUPAC Name
C19H27NO3Chemical Formula
317.4 g/molMolecular Weight
nateglinide; 105816-04-4; Starlix; Starsis; senaglinide; Fastic; AY-4166; SDZ-DJN-608; Trazec; A-4166; D-Nateglinide; DJN 608; DJN-608; nateglinida; DTXSID9040687; AY 4166; SDZ DJN 608; AY4166; nateglinidum; A 4166; CHEMBL783; 41X3PWK4O2; NSC-758695; A4166; (-)-N-(trans-4-Isopropylcyclohexanecarbonyl)-D-phenylalanine; CHEBI:31897; D-phenylalanine, N-((trans-4-(1-methylethyl)cyclohexyl)carbonyl)-; Nateglinide [USAN:USP:INN:BAN]; (2R)-3-phenyl-2-{[(1r,4r)-4-(propan-2-yl)cyclohexyl]formamido}propanoic acid; nate-glinide; D-Phenylalanine, N-[[trans-4-(1-methylethyl)cyclohexyl]carbonyl]-; trans-N-((4-(1-Methylethyl)cyclohexyl)carbonyl)-D-phenylalanine; NATEGLINIDE (USP-RS); NATEGLINIDE [USP-RS]; NATEGLINIDE (EP MONOGRAPH); NATEGLINIDE [EP MONOGRAPH]; NATEGLINIDE (USP MONOGRAPH); NATEGLINIDE [USP MONOGRAPH]; Nateglinide (USAN:USP:INN:BAN); trans-N-{[4-(1-methylethyl)cyclohexyl]carbonyl}-D-phenylalanine; (2R)-3-phenyl-2-(((1r,4r)-4-(propan-2-yl)cyclohexyl)formamido)propanoic acid; RefChem:56719; Nateglinide (JP17/USP/INN); A10BX03; OELFLUMRDSZNSF-OFLPRAFFSA-N; NCI-C61858; N-(trans-4-(1-Methylethyl)cyclohexanecarbonyl)-D-phenylalanine; 642-283-9; N-(2-(4-(cyclohexylcarbamoylsulfamoyl)phenyl)ethyl)-5-methylpyrazine-2-carboxamide; OELFLUMRDSZNSF-BRWVUGGUSA-N; 105816-06-6; Nateglinide [INN]; Nateglinide EP impurity C; SDZ-DJN 608; (2R)-3-phenyl-2-[(4-propan-2-ylcyclohexanecarbonyl)amino]propanoic acid; (r)-2-((1r,4r)-4-isopropylcyclohexanecarboxamido)-3-phenylpropanoic acid; N-[[cis-4-(1-Methylethyl)cyclohexyl]carbonyl]-D-phenylalanine(Nateglinide Impurity); MFCD00875706; XTM4DQP5S5; n-[[trans-4-(1-methylethyl)cyclohexyl]carbonyl]-d-phenylalanine; 105746-37-0; N-[(trans-4-Isopropylcyclohexyl)carbonyl]-D-phenylalanine; DTXCID7020687; N-((cis-4-Isopropylcyclohexyl)carbonyl)-D-phenylalanine; D-Phenylalanine, N-((cis-4-(1-methylethyl)cyclohexyl)carbonyl)-; N-((cis-4-(1-Methylethyl)cyclohexyl)carbonyl)-D-phenylalanine; N-{[trans-4-(propan-2-yl)cyclohexyl]carbonyl}-D-phenylalanine; (R)-2-(cis-4-Isopropylcyclohexanecarboxamido)-3-phenylpropanoic acid; D-Phenylalanine, N-((4-(1-methylethyl)cyclohexyl)carbonyl)-, cis-; (2R)-2-[(4-isopropylcyclohexanecarbonyl)amino]-3-phenyl-propanoic acid; (2R)-2-[[oxo-(4-propan-2-ylcyclohexyl)methyl]amino]-3-phenylpropanoic acid; (R)-2-rel-((1r,4R)-4-Isopropylcyclohexanecarboxamido)-3-phenylpropanoic acid; SMR000466372; CAS-105816-04-4; UNII-41X3PWK4O2; D-Phenylalanine, N-[[4-(1-methylethyl)cyclohexyl]carbonyl]-, cis-; Nateglinide CRS; Starlix;; Fastic;; NCGC00095121-01; Starsis (TN); Nateglinide, Starlix; YM-026; Nateglinide (Standard); Nateglinide cis Impurity; NATEGLINIDE [MI]; UNII-XTM4DQP5S5; NATEGLINIDE [JAN]; (1s,4S)-D-Nateglinide; NATEGLINIDE [USAN]; NATEGLINIDE [VANDF]; Nateglinide impurity C CRS; A1L9H; NATEGLINIDE [MART.]; SCHEMBL22088; NATEGLINIDE [WHO-DD]; Nateglinide impurity C [EP]; MLS000759500; MLS001424043; MLS003915639; MLS006011429; BIDD:GT0257; Nateglinide cis-isomer [USP]; SCHEMBL303827; NATEGLINIDE [EMA EPAR]; GTPL6833; orb1227055; orb1307803; SCHEMBL9232138; Nateglinide (JP18/USP/INN); CHEMBL2114389; CHEBI:94617; HY-B0422R; MSK7194; NATEGLINIDE [ORANGE BOOK]; GLXC-07314; HMS2051G20; HMS2089A10; HMS2235O08; HMS3675G17; HMS3715F12; HY-B0422; Tox21_111432; BBL033469; BDBM50344967; EBC-11228; EBC-12167; STK647123; AKOS005577723; AKOS015841612; AKOS015960899; Nateglinide, >=98% (HPLC), solid; Tox21_111432_1; AC-1690; CCG-100898; DB00731; FN26165; KS-5143; NC00148; NSC 758695; NCGC00095121-12; NCGC00095121-16; NCGC00178741-03; NCGC00271534-02; NCGC00271534-03; N0912; NATEGLINIDE CIS-ISOMER [USP IMPURITY]; NATEGLINIDE IMPURITY C [EP IMPURITY]; NS00000602; NS00073312; SW197528-2; D01111; EN300-303645; AB00639979-06; AB00639979-08; AB00639979-09; AB00639979-11; AB00639979_12; EN300-27126236; F979686; A1-02996; Q2254797; BRD-K44353683-001-07-5; BRD-K44353683-001-08-3; Q27166439; n-(trans-4-isopropylcyclohexylcarbonyl)-d-phenylalanine; Z1514053266; Nateglinide, European Pharmacopoeia (EP) Reference Standard; ((1r,4R)-4-isopropylcyclohexane-1-carbonyl)-D-phenylalanine; 2-[(4-Isopropyl-cyclohexanecarbonyl)-amino]-3-phenyl-propionic acid; N-[(1r,4R)-4-(Propan-2-yl)cyclohexane-1-carbonyl]-D-phenylalanine; Nateglinide, United States Pharmacopeia (USP) Reference Standard; (2R)-3-phenyl-2-{[4-(propan-2-yl)cyclohexyl]formamido}propanoic acid; (R)-2-((1s,4S)-4-isopropylcyclohexanecarboxamido)-3-phenylpropanoic acid; {N}-[({TRANS}-4-ISOPROPYLCYCLOHEXYL)CARBONYL]-D-PHENYLALANINE; D-Phenylalanine, N-((4-(1-methylethyl)cyclohexyl)carbonyl)-, trans-; (R)-2-rel-((1r,4R)-4-Isopropylcyclohexanecarboxamido)-3-phenylpropanoicacidSynonyms
